ArticleJournal of orthopaedic surgery and research2025
RIPK3 is spatially associated with cartilage degeneration in osteoarthritis: integrative transcriptomic and histological analysis.
Article in Journal of orthopaedic surgery and research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundOsteoarthritis (OA) is a degenerative joint disease characterized by progressive cartilage loss, yet its molecular underpinnings remain incompletely defined. This study aimed to investigate the regional expression pattern of receptor-interacting protein kinase 3 (RIPK3) in OA cartilage and its association with histopathological severity.
methodsCartilage samples were collected from OA patients and categorized into normal tissue (NT), junction tissue (JT), and lesioned tissue (LT). RNA sequencing was performed to identify differentially expressed genes (DEGs) between NT and JT. Gene enrichment analysis was conducted to explore functional pathways. Immunofluorescence staining was used to validate RIPK3 protein expression and localization.
resultsTranscriptomic analysis identified 140 differentially expressed genes (DEGs) between NT and JT, with several genes, including RIPK3, CCL19, and ITLN1, significantly up-regulated in JT. RIPK3 expression showed a log
conclusionsRIPK3 is spatially enriched in degenerative regions of OA cartilage and associates with histopathological damage, suggesting its potential involvement in disease progression. These findings provide new insight into the molecular landscape of OA and support RIPK3 for further evaluation as a biomarker and potential therapeutic target.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.